Diffusion Pharmaceuticals Inc (DFFN) stock is up 287.18% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives DFFN stock a score of 91 out of a possible 100.
That rank is influenced by a fundamental score of 94. In addition to the average rating from Wall Street analysts, DFFN stock has a mean target price of 2.75. This means analysts expect the stock to rise 82.12% over the next 12 months. DFFN's rank also includes a short-term technical score of 90. The long-term technical score for DFFN is 89.
What's Happening with DFFN Stock Today
Diffusion Pharmaceuticals Inc (DFFN) stock is up 1.62% while the S&P 500 is lower by -0.98% as of 10:10 AM on Thursday, Feb 18. DFFN is up $0.02 from the previous closing price of $1.49 on volume of 3,430,603 shares. Over the past year the S&P 500 has gained 14.97% while DFFN is up 287.18%. DFFN lost -$0.49 per share in the over the last 12 months.